226 related articles for article (PubMed ID: 15187154)
21. Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation.
Quinn LS; Steinmetz B; Maas A; Ong L; Kaleko M
J Cell Physiol; 1994 Jun; 159(3):387-98. PubMed ID: 8188756
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin reduces insulin-like growth factor-1 signaling in differentiating C2C12 mouse myoblast cells in an HMG-CoA reductase inhibition-independent manner.
Ogura T; Tanaka Y; Nakata T; Namikawa T; Kataoka H; Ohtsubo Y
J Toxicol Sci; 2007 Feb; 32(1):57-67. PubMed ID: 17327694
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
24. Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts.
Strle K; McCusker RH; Tran L; King A; Johnson RW; Freund GG; Dantzer R; Kelley KW
J Neuroimmunol; 2007 Aug; 188(1-2):48-55. PubMed ID: 17572510
[TBL] [Abstract][Full Text] [Related]
25. Sodium fluoride induced skeletal muscle changes: Degradation of proteins and signaling mechanism.
Shenoy PS; Sen U; Kapoor S; Ranade AV; Chowdhury CR; Bose B
Environ Pollut; 2019 Jan; 244():534-548. PubMed ID: 30384060
[TBL] [Abstract][Full Text] [Related]
26. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
Sharples AP; Al-Shanti N; Stewart CE
J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
[TBL] [Abstract][Full Text] [Related]
27. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis.
Frost RA; Lang CH; Gelato MC
Endocrinology; 1997 Oct; 138(10):4153-9. PubMed ID: 9322924
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
29. Effects of insulin like growth factors on early embryonic chick limb myogenesis.
Mohammed RH; Anderton H; Brameld JM; Sweetman D
PLoS One; 2017; 12(10):e0185775. PubMed ID: 28972999
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3.
Al-Shanti N; Stewart CE
J Cell Biochem; 2012 Mar; 113(3):923-33. PubMed ID: 22033984
[TBL] [Abstract][Full Text] [Related]
31. Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor.
Thulasi R; Dias P; Houghton PJ; Houghton JA
Cell Growth Differ; 1996 Apr; 7(4):531-41. PubMed ID: 9052994
[TBL] [Abstract][Full Text] [Related]
32. Cooperation between Shh and IGF-I in promoting myogenic proliferation and differentiation via the MAPK/ERK and PI3K/Akt pathways requires Smo activity.
Madhala-Levy D; Williams VC; Hughes SM; Reshef R; Halevy O
J Cell Physiol; 2012 Apr; 227(4):1455-64. PubMed ID: 21618536
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effect of glucocorticoids and IGF-1 on myogenic differentiation through the Akt/GSK-3β pathway in C2C12 myoblasts.
Fang XB; Song ZB; Xie MS; Liu YM; Zhang WX
Int J Neurosci; 2020 Nov; 130(11):1125-1135. PubMed ID: 32070170
[No Abstract] [Full Text] [Related]
34. PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: a novel role for PD98059.
Al-Shanti N; Stewart CE
J Endocrinol; 2008 Jul; 198(1):243-52. PubMed ID: 18467380
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism.
James PL; Stewart CE; Rotwein P
J Cell Biol; 1996 May; 133(3):683-93. PubMed ID: 8636241
[TBL] [Abstract][Full Text] [Related]
36. Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cells.
Cheng ZQ; Adi S; Wu NY; Hsiao D; Woo EJ; Filvaroff EH; Gustafson TA; Rosenthal SM
J Endocrinol; 2000 Oct; 167(1):175-82. PubMed ID: 11018765
[TBL] [Abstract][Full Text] [Related]
37. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
Wilson EM; Tureckova J; Rotwein P
Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
[TBL] [Abstract][Full Text] [Related]
38. IL-1β and TNF-α Modulation of Proliferated and Committed Myoblasts: IL-6 and COX-2-Derived Prostaglandins as Key Actors in the Mechanisms Involved.
Alvarez AM; DeOcesano-Pereira C; Teixeira C; Moreira V
Cells; 2020 Sep; 9(9):. PubMed ID: 32882817
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α.
Ono Y; Sakamoto K
PLoS One; 2017; 12(7):e0182040. PubMed ID: 28742154
[TBL] [Abstract][Full Text] [Related]
40. EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines.
Minami M; Koyama T; Wakayama Y; Fukuhara S; Mochizuki N
Mol Biol Cell; 2011 Sep; 22(18):3508-19. PubMed ID: 21795402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
